MARKET COMPOSITE
Market TodayThemes and Stocks SummaryThematic Stock SearchDaily Refresh Schedule
FUSN - Fusion Pharmaceuticals Inc
$6.13
-0.07(-1.13%)6:00:01 PM 11/26/2021
Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to antibodies and other targeting molecules in order to selectively deliver the alpha particle payloads to tumors. Its lead product candidate is FPI-1434 that is in Phase 1 clinical trials as a monotherapy in patients with solid tumors expressing insulin-like growth factor 1 receptor. The company is also conducting additional preclinical studies of FPI-1434 in combination with approved checkpoint inhibitors and DNA damage response inhibitors to further assess the anti-tumor activity, and dosing schedule and pharmacodynamics of the combinations. In addition, it is progressing its earlier-stage product candidate, FPI-1966 into clinical development for the treatment of head and neck, and bladder cancers expressing fibroblast growth factor receptor. The company was founded in 2014 and is headquartered in Hamilton, Canada.
Stock Chart
leak data

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Summary:

  • Volatility is at a recent 2 week high. A high volatility of stock movement indicates uncertainty.
  • A moving average of Short volume ratio is at a recent 2 week high. A high short volume ratio indicate selling presures.
Stock Statistics
MarketCap267M
PE Ratio
PEG Ratio
P/B
P/S (ttm)
Earning Growth (QoQ)
Revenue Growth (QoQ)
Short %1%
Held by Institutions %80%
1 Day Vol Adjusted Return-0.5
1 Month Vol Adjusted Return-6.5
3 Month Vol Adjusted Return-14.8
6 Month Vol Adjusted Return-11.2
20 Days SMA Price ZScore-1.0
50 Days SMA Price ZScore-1.5
12 -26 Days PPO-5.5
1 Month Average Short Volume Ratio54.2
1 Day Volume Change ZScore-1.1
1 Month Daily Vol2.3
Related Topics
leak data

Related Topics

Peers

Related Peers

Stock news